Submission Details
| 510(k) Number | K240859 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 28, 2024 |
| Decision Date | August 21, 2024 |
| Days to Decision | 146 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K240859 is an FDA 510(k) clearance for the Glidewire GT-R, a Wire, Guide, Catheter (Class II — Special Controls, product code DQX), submitted by Terumo Corporation (Tokyo, JP). The FDA issued a Cleared decision on August 21, 2024, 146 days after receiving the submission on March 28, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1330.
| 510(k) Number | K240859 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 28, 2024 |
| Decision Date | August 21, 2024 |
| Days to Decision | 146 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQX — Wire, Guide, Catheter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1330 |